Acute Asthma Flashcards
What is the pathophysiology behind asthma?
- Airway hyper-responsiveness, leading to (a) bronchospasm – constriction of smooth muscle in small airways (bronchi and bronchioles) – and (b) airway inflammation, leading to mucus secretion.
- Reversible
- No gold standard definition.
What percentage of children are affected by asthma?
- Affects 15% of children.
- Not usually diagnosed in those under 2 years old, due to the difficulty of distinguishing from viral-induced wheeze and frequent URTIs.
What are common signs and symptoms of asthma?
- Symptoms:
- SOB and dry cough, which often has diurnal variation, being worse at night and in the morning.
- Signs:
- Wheeze
- Hyperinflation
- Pulsus paradoxus in a severe attack.
- Reduced air entry due to mucous plug in attack.
Which features strongly suggest a diagnosis of asthma?
- reversibility to bronchodilators (>12% change in PEFR or FEV1).
- Episodic time course.
- Triggers: exercise, stress, pets, viral URTIs, cold air, and tobacco smoke.
- Eczema or hay fever may also be present.
Which features might suggest another diagnosis to be more likely than asthma?
- Dizziness and tingling (suggests panic attack).
- Symptoms only with colds.
- Productive cough without wheeze.
- Voice disturbances.
- Smoking. However, if someone has pre-existing asthma, don’t assume it has become COPD just because they later start smoking.
What are the risk factors for asthma?
- Atopy
* Family history of atopy or asthma.
Which investigations are carried out in a patient with suspected asthma?
- Diagnosis with lung function testing:
- Spirometry: FEV1/FVC ratio <0.7 confirms obstructive airway disease.
- Then do bronchodilator reversibility (BDR) test, with ≥12% improvement in FEV1 +ve for asthma.
- In adults, diagnosis should be confirmed with fractional exhaled nitric oxide test (FeNO), with ≥40 ppb +ve for asthma. Use in kids (5-16) only if diagnosis uncertain.
- If spirometry, BDR, or FeNO -ve, consider 2-4 weeks of peak flow monitoring. >20% variability is +ve for asthma.
- Specialist referral if these tests are -ve but symptoms continue.
- Who to test:
- NICE advise formal testing for all ≥5 years old.
- British Thoracic Society advise formal testing for those ≥5 years old with low or intermediate probability based on clinical history, but go straight to treatment if high probability (and then only test formally if there is a poor response).
- In children who cannot perform spirometry – generally those <5 years old – use clinical diagnosis and trial of treatment.
Other tests:
- CXR in adults to rule out other causes. May show hyperinflation in asthma.
- Allergy testing – skin prick testing or allergen-specific IgE in blood – can identify a specific trigger if it is suspected, but is not routinely recommended.
How is asthma managed?
- Overview:
- Aim to achieve patient control over management including an asthma action plan, PEFR monitoring, and symptom diary.
- Teach inhaler technique as many patients have trouble.
- Inhaled steroids reduce nocturnal symptoms quickly, but wider effects takes months, so users need to know to be patient.
- In addition to inhalers:
- Remove any identified allergens.
- Annual flu vaccine, which is via nasal spray in kids.
- Smoking cessation. Among its many harms, smoking weakens the effectiveness of steroids.
- Routine antibiotics are not recommended, even if there is purulent sputum as this can be part of normal inflammation. Of course, clinical judgement can override this.
- Stepwise medical treatment
- Most people are at steps 1-2.
- Start at a level appropriate to disease severity.
- Remember: you can move down as well as up!
- Inhaled short acting β2 agonist (SABA) as required:
* Salbutamol 100 μg/puff. Use 2 puffs before exercise if likely to bring on symptoms.
* Move to step 2 if using >3 times/week, waking at night, or has acute asthma exacerbation.
- Inhaled short acting β2 agonist (SABA) as required:
- Add inhaled corticosteroid (ICS):
* Fluticasone, beclometasone, or budesonide.
* Start at low dose.
- Add inhaled corticosteroid (ICS):
- Add leukotriene receptor antagonist (LTRA):
* Montelukast or zafirlukast.
- Add leukotriene receptor antagonist (LTRA):
- Add inhaled long-acting β2 agonist (LABA):
* Salmeterol or formoterol, in combination inhaler with ICS.
* Continue LTRA if felt to be effective.
* If remains uncontrolled, switch ICS/LABA combo to maintenance and reliever therapy (MART), a combo which includes a fast-acting LABA (e.g. formoterol) and is used as both maintenance and reliever.
- Add inhaled long-acting β2 agonist (LABA):
- Increase ICS dose until effective or trial further drug (theophylline or long-acting muscarinic antagonist).
6. Refer to specialist for consideration of systemic immunomodulators such as:
* Prednisolone PO.
* Monoclonal antibodies: omalizumab (anti IgE); mepolizumab, reslizumab, or benralizumab (anti IL5).
- Increase ICS dose until effective or trial further drug (theophylline or long-acting muscarinic antagonist).
6. Refer to specialist for consideration of systemic immunomodulators such as:
- 5-16 years old
As for >16 years, except:
- If LTRA insufficient, switch to (don’t add) LABA.
- 0-4 years old
As for 5-16 years, except:
- Stop ICS after 8 weeks to confirm response (and diagnosis), restarting if symptoms recur.
- Don’t add LABA; just refer to specialist after step 3.
In which medications should caution be taken in patients with asthma?
- β-blockers:
- Contraindicated in asthma as they lead to bronchospasm.
- Non-cardioselective β-blockers especially problematic: propranolol, timolol.
- NSAIDs and ASA:
- Can trigger bronchospasm, either in existing patients or as a standalone cause of new asthma.
- Affects <10% of asthma patients.
- OK to use if previously taken, but probably avoid if never taken, and use clopidogrel instead.
- Can occur as Samter’s triad: aspirin sensitivity, polyps ± rhinitis, and asthma.
What is the defining criteria for acute severe asthma?
- Acute severe asthma
≥1 of:
- PEFR 33-50%.
- RR>25. >30 if 5-12 years old, >50 if <5 years old.
- HR>110. >120 if 5-12 years old, >130 if <5 years old.
- Can’t talk fully.
What is the defining criteria for life-threatening asthma?
- ≥1 of:
- PEFR <33%.
- SpO2 <92%, PaO2 <8 kPa, or normal PaCO2.
- Altered mental status.
- Arrhythmias, ↓BP.
- Silent chest or poor respiratory effort, cyanosis.
- If they are drowsy/sleeping, check if they can be roused to determine if it is pathological.
What is the defining criteria for near-fatal asthma?
↑CO2 or needing ventilation.
How is acute exacerbation of asthma managed?
- Basics, SONSIS:
- Sit up.
- 100% O2, aiming for SpO2 94-8%.
- Oxygen-driven, Nebulized SABA ± Ipratropium.
- Steroids PO/IV. Takes up to 4 hours to have an effect so give early, preferably PO.
- Further options, MAGAS:
- IV MAGnesium sulfate.
- IV Aminophylline – including a loading dose if not on theophylline already – or IV SABA.
- ITU transfer if there is ↑CO2 or ventilation is required.
Discharge when stable, PEFR>75%, and on discharge drugs for 12 hours:
- Prednisolone PO: at least 3 days in children, 5 days in adults, or until recovery.
- ICS
- Written treatment plan.
- GP visit in 2 days.
- Outpatient clinic in 4 weeks.
What causes occupational asthma?
- Causes
- High molecular mass substances: flour, wood dust, lab animal allergens. May have specific, detectable IgE.
- Low molecular mass substances – e.g. isocyanates (furniture foam, paint spray), welding fumes, oil mists – which act as haptens and bind to human proteins. Often hard to detect specific IgE.
How might occupational asthma present?
- Typical asthmatic/hypersensitivity symptoms: cough, SOB, wheeze, rhinitis, conjunctivitis.
- Onset within 1 year of starting job.
- Initial latent interval without symptoms – weeks to months – while hypersensitivity develops.
- Symptoms may occur at work, or hours post-exposure in the evening or night, reflecting a delayed response.
- Symptoms worsen throughout week, but improve at weekends and holidays.